Search results for SRSF2

222 hits were found for SRSF2

# Family MCID Name MIFTS Score
1
P CHR285 Chronic Myelomonocytic Leukemia 59 23.976
2
MYL009 Myelodysplastic Syndrome 67 17.359
3
AGG002 Aggressive Systemic Mastocytosis 49 16.017
4
MYL005 Myelofibrosis 70 13.444
5
P MST009 Mastocytosis 64 12.814
6
c LKM061 Leukemia, Acute Myeloid 83 12.758
7
DWN001 Down Syndrome 70 12.543
8
SYS004 Systemic Mastocytosis 62 12.423
9
P LCT001 Lactic Acidosis 50 12.402
10
CHR286 Chronic Neutrophilic Leukemia 42 11.357
11
ACT186 Acute Megakaryoblastic Leukemia in Down Syndrome 30 11.053
12
c AMY091 Amyotrophic Lateral Sclerosis 1 88 10.409
13
P SPN046 Spinal Muscular Atrophy 62 10.326
14
P RTN008 Retinitis Pigmentosa 79 10.126
15
IMM167 Immune Deficiency Disease 77 10.126
16
HLT001 Holt-Oram Syndrome 66 10.126
17
c DLT002 Dilated Cardiomyopathy 79 10.126
18
SYS077 Systemic Mastocytosis with Associated Hematologic Neoplasm 24 8.715
19
ATY042 Atypical Chronic Myeloid Leukemia 50 8.409
20
P MLN069 Melanoma, Uveal 59 8.372
21
SMH001 Sm-Ahnmd 31 7.507
22
MYL075 Myelodysplastic/myeloproliferative Neoplasm 51 7.476
23
IND002 Indolent Systemic Mastocytosis 41 7.302
24
PTS001 Patau Syndrome 55 7.302
25
END043 Endometrial Stromal Tumor 34 7.160
26
EXT007 Extracutaneous Mastocytoma 38 7.160
27
c CHR418 Chronic Leukemia 48 7.160
28
END031 Endometrial Stromal Sarcoma 45 7.160
29
BNM001 Bone Marrow Cancer 45 7.160
30
P LKM002 Leukemia 66 4.184
31
P MYL006 Myeloid Leukemia 60 4.178
32
P HPT023 Hepatocellular Carcinoma 95 2.441
33
LNG039 Lung Squamous Cell Carcinoma 57 2.203
34
MYL031 Myeloproliferative Neoplasm 66 2.164
35
P LNG064 Lung Cancer Susceptibility 3 70 2.134
36
P BLD134 Bladder Cancer 79 2.074
37
RPD005 Rapidly Involuting Congenital Hemangioma 48 1.864
38
P BRS047 Breast Cancer 97 1.855
39
P LNG032 Lung Cancer 98 1.851
40
P KDN017 Kidney Cancer 60 1.831
41
P LKM071 Leukemia, Chronic Lymphocytic 74 1.744
42
RNL114 Renal Cell Carcinoma, Nonpapillary 79 1.606
43
P GST053 Gastric Cancer 82 1.502
44
P OVR042 Ovarian Cancer 88 1.497
45
BLD173 Bladder Small Cell Carcinoma 44 1.426
46
ATX038 Ataxia and Polyneuropathy, Adult-Onset 45 1.318
47
c LKM063 Leukemia, Chronic Myeloid 71 1.318
48
SPL018 Splenomegaly 47 1.318
49
CHR178 Chromosomal Triplication 34 1.318
50
P ATX030 Ataxia-Telangiectasia 80 1.302
51
TLN003 Telangiectasis 51 1.302
52
ACT098 Acute Erythroid Leukemia 55 1.285
53
c ACT073 Acute Leukemia 59 1.231
54
P MLN008 Melanoma 75 1.231
55
P NTR004 Neutropenia 62 1.191
56
P HRP006 Herpes Simplex 65 1.191
57
P PRS040 Prostate Cancer 95 1.150
58
P TMR010 Tumor Predisposition Syndrome 69 1.150
59
GST040 Gastric Adenocarcinoma 66 1.128
60
47X002 47,xyy 48 1.126
61
HYP266 Hypoxia 56 1.102
62
CLR030 Clear Cell Renal Cell Carcinoma 54 1.102
63
P NSP012 Nasopharyngeal Carcinoma 60 1.048
64
c ACT134 Acute Liver Failure 57 1.018
65
ADN011 Adenoid Cystic Carcinoma 68 1.009
66
END057 Endometrial Cancer 71 1.009
67
ADN089 Adenosquamous Lung Carcinoma 49 1.009
68
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 1.009
69
CHL149 Childhood Acute Myeloid Leukemia 42 0.984
70
OVR094 Ovarian Epithelial Cancer 39 0.946
71
PLY001 Polycythemia Vera 69 0.938
72
P PLY018 Polycythemia 56 0.938
73
P ESS003 Essential Thrombocythemia 68 0.917
74
GLM045 Glioma 62 0.913
75
P SPR120 Supranuclear Palsy, Progressive, 1 69 0.901
76
ACT113 Acute Myeloblastic Leukemia with Maturation 46 0.901
77
GST103 Gastric Cancer, Hereditary Diffuse 68 0.874
78
BRS099 Breast Ductal Carcinoma 61 0.874
79
SML009 Small Intestine Adenocarcinoma 57 0.874
80
MNN043 Meningioma, Familial 79 0.855
81
c SML038 Small Cell Cancer of the Lung 69 0.843
82
P NRB001 Neuroblastoma 66 0.843
83
ANT039 Antisynthetase Syndrome 55 0.760
84
c CHR064 Chronic Monocytic Leukemia 36 0.760
85
c MSM022 Mismatch Repair Cancer Syndrome 1 69 0.713
86
c GLM043 Glioma Susceptibility 9 30 0.713
87
c CLR087 Colorectal Cancer 12 34 0.713
88
c GLM047 Glioma Susceptibility 3 32 0.713
89
c GLM025 Glioma Susceptibility 2 29 0.713
90
P GLM040 Glioma Susceptibility 1 70 0.713
91
P OLG002 Oligodendroglioma 66 0.713
92
CLN015 Colon Adenocarcinoma 64 0.713
93
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 60 0.713
94
GLB002 Glioblastoma 67 0.692
95
P PNC035 Pancreatic Cancer 86 0.692
96
P THR014 Thrombocytopenia 66 0.648
97
THR004 Thrombocytosis 52 0.617
98
JVN004 Juvenile Myelomonocytic Leukemia 67 0.510
99
ESP021 Esophageal Cancer 84 0.504
100
IRN008 Iron Overload in Africa 51 0.504
101
LYM143 Lymphoma, Non-Hodgkin, Familial 79 0.504
102
RNL065 Renal Cell Carcinoma, Papillary, 1 79 0.504
103
RJS001 Ruijs-Aalfs Syndrome 47 0.504
104
NNL005 Non-Alcoholic Fatty Liver Disease 63 0.504
105
HPT079 Hepatoid Adenocarcinoma 39 0.504
106
P FLL037 Follicular Lymphoma 73 0.504
107
c CHL136 Cholestasis, Progressive Familial Intrahepatic, 2 57 0.504
108
c HPT073 Hepatitis C Virus 71 0.504
109
RNL119 Renal Cell Carcinoma, Xp11-Associated 42 0.504
110
ADL096 Adult Hepatocellular Carcinoma 60 0.504
111
MTN001 Metanephric Adenoma 39 0.504
112
LNG012 Lung Occult Squamous Cell Carcinoma 20 0.504
113
PPL004 Papillary Squamous Carcinoma 39 0.504
114
c PRG047 Progressive Familial Intrahepatic Cholestasis 64 0.504
115
PDT042 Pediatric Hepatocellular Carcinoma 50 0.504
116
PTY007 Pityriasis Rotunda 26 0.504
117
FBR086 Fibrolamellar Carcinoma 59 0.504
118
HPT011 Hepatocellular Clear Cell Carcinoma 45 0.504
119
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 20 0.504
120
P MST002 Mast-Cell Leukemia 50 0.447
121
RFR010 Refractory Anemia 49 0.374
122
c PLM164 Pulmonary Hypertension, Primary, 1 80 0.347
123
P BCL017 B-Cell Lymphoma 57 0.347
124
HRT015 Heritable Pulmonary Arterial Hypertension 46 0.347
125
P LTR001 Lateral Sclerosis 58 0.283
126
HMT002 Hematologic Cancer 61 0.283
127
P BDY004 Body Mass Index Quantitative Trait Locus 11 83 0.245
128
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.245
129
c BDY012 Body Mass Index Quantitative Trait Locus 7 43 0.245
130
P LKM062 Leukemia, Acute Lymphoblastic 69 0.245
131
P PLM037 Pulmonary Hypertension 69 0.245
132
TRD008 Triiodothyronine Receptor Auxiliary Protein 33 0.245
133
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 0.245
134
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 0.245
135
c BDY006 Body Mass Index Quantitative Trait Locus 8 43 0.245
136
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.245
137
CHR635 Chromosome 5q Deletion Syndrome 50 0.245
138
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 0.245
139
c BDY019 Body Mass Index Quantitative Trait Locus 18 47 0.245
140
c BDY020 Body Mass Index Quantitative Trait Locus 19 51 0.245
141
PNC001 Pancytopenia 52 0.245
142
P PRP019 Peripheral Nervous System Disease 57 0.245
143
BLS007 Blastic Plasmacytoid Dendritic Cell 37 0.245
144
P NRP001 Neuropathy 59 0.245
145
DND018 Dendritic Cell Tumor 41 0.245
146
P HYP098 Hypereosinophilic Syndrome 66 0.245
147
RSP023 Rasopathy 54 0.200
148
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 58 0.200
149
P MNS018 Monosomy 7 Myelodysplasia and Leukemia Syndrome 1 30 0.200
150
P LYM118 Lymphoma 69 0.200
151
c FNC028 Fanconi Anemia, Complementation Group L 46 0.200
152
HTC003 Hutchinson-Gilford Progeria Syndrome 65 0.200
153
ANG046 Angioimmunoblastic T-Cell Lymphoma 51 0.200
154
CNG034 Congestive Heart Failure 69 0.200
155
P PLY011 Polycystic Ovary Syndrome 57 0.200
156
HYP043 Hyperandrogenism 47 0.200
157
BLD053 Blood Platelet Disease 51 0.200
158
P MSC003 Muscular Atrophy 52 0.200
159
GLL048 Glial Tumor 52 0.200
160
ACT200 Acute Monoblastic Leukemia 40 0.200
161
OST012 Osteoarthritis 77 0.200
162
RNX001 Runx1 Familial Platelet Disorder with Associated Myeloid Malignancies 13 0.200
163
P MSC005 Muscular Dystrophy 66 0.200
164
P ALZ034 Alzheimer Disease 87 0.141
165
MLT161 Multinucleated Neurons, Anhydramnios, Renal Dysplasia, Cerebellar Hypoplasia, and Hydranencephaly 55 0.141
166
DNY001 Denys-Drash Syndrome 57 0.141
167
c CNR013 Cone-Rod Dystrophy 12 36 0.141
168
c MCR115 Microvascular Complications of Diabetes 5 65 0.141
169
FRN006 Frontotemporal Dementia 68 0.141
170
c SPN265 Spinocerebellar Ataxia 36 42 0.141
171
ACT119 Acute Promyelocytic Leukemia 62 0.141
172
P MCP040 Mucopolysaccharidosis-Plus Syndrome 70 0.141
173
HLX001 Helix Syndrome 47 0.141
174
DFF005 Diffuse Large B-Cell Lymphoma 55 0.141
175
P GRF003 Graft-Versus-Host Disease 71 0.141
176
PRT013 Portal Hypertension 59 0.141
177
CRB004 Cerebral Artery Occlusion 46 0.141
178
INT395 Intracranial Meningioma 48 0.141
179
P CNR004 Cone-Rod Dystrophy 2 75 0.141
180
CST001 Costello Syndrome 68 0.141
181
c FNC027 Fanconi Anemia, Complementation Group a 81 0.141
182
c TRC092 Trichorhinophalangeal Syndrome, Type I 54 0.141
183
P MYC084 Mycobacterium Tuberculosis 1 68 0.141
184
HMN044 Human Immunodeficiency Virus Type 1 76 0.141
185
c NRF024 Neurofibromatosis, Type I 76 0.141
186
OCL008 Oculopharyngeal Muscular Dystrophy 53 0.141
187
P NNN008 Noonan Syndrome 1 76 0.141
188
CTN028 Cutaneous Telangiectasia and Cancer Syndrome, Familial 70 0.141
189
P LFR001 Li-Fraumeni Syndrome 73 0.141
190
c ACQ017 Acquired Von Willebrand Syndrome 48 0.141
191
DFC004 Deficiency Anemia 74 0.141
192
HRY003 Hairy Cell Leukemia 61 0.141
193
P ADN016 Adenocarcinoma 63 0.141
194
RHB002 Rhabdoid Meningioma 32 0.141
195
SQM006 Squamous Cell Carcinoma 59 0.141
196
P ATS308 Autosomal Dominant Cerebellar Ataxia 64 0.141
197
c THR001 Thrombocytopenia Due to Platelet Alloimmunization 60 0.141
198
SKN016 Skin Disease 62 0.141
199
GRN003 Granulomatous Dermatitis 32 0.141
200
VCC001 Vaccinia 49 0.141
201
c MCP050 Mucopolysaccharidosis, Type Ii 73 0.141
202
PLM129 Pulmonary Disease, Chronic Obstructive 74 0.141
203
PLT019 Platelet Disorder, Familial, with Associated Myeloid Malignancy 40 0.141
204
DRM006 Dermatitis 62 0.141
205
PRP030 Purpura 54 0.141
206
GST045 Gastroenteritis 58 0.141
207
MYL074 Myelodysplastic Syndrome with Excess Blasts 38 0.141
208
P THL005 Thalassemia 56 0.141
209
CYT019 Cytogenetically Normal Acute Myeloid Leukemia 30 0.141
210
HST008 Histiocytic and Dendritic Cell Cancer 30 0.141
211
P EYD002 Eye Disease 57 0.141
212
SCR001 Secretory Meningioma 40 0.141
213
LYM002 Lymphoplasmacyte-Rich Meningioma 35 0.141
214
SKN019 Skin Melanoma 70 0.141
215
P NRF002 Neurofibromatosis 60 0.141
216
c ACT135 Acute Graft Versus Host Disease 51 0.141
217
c PSD047 Pseudo-Turner Syndrome 52 0.141
218
INH023 Inherited Cancer-Predisposing Syndrome 53 0.141
219
c ACT254 Acute Myeloid Leukemia with T(9;22)(q34.1;q11.2) 8 0.141
220
P RRT020 Rare Tumor 39 0.141
221
ARG006 Aregenerative Anemia 28 0.141
222
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 45 0.141
Content
Loading form....